Improving the treatment of neuropsychiatric symptoms in nursing home residents suffering from dementia

ISRCTN ISRCTN43578978
DOI https://doi.org/10.1186/ISRCTN43578978
Secondary identifying numbers LT 44-076
Submission date
30/01/2010
Registration date
10/06/2010
Last edited
25/04/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Michael Rapp
Scientific

Psychiatric University Hospital St. Hedwig
Grosse Hamburger Str. 5-11
Berlin
10115
Germany

Phone +49 2311 2057
Email michael.rapp@charite.de

Study information

Study designCluster randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet (in German)
Scientific titleEvaluation of a combined guideline implementation protocol for neuropsychiatric symptoms in nursing home residents suffering from dementia
Study acronymVIDEANT
Study objectivesThe implementation of guideline-driven training and occupational therapy interventions will reduce neuropsychiatric symptoms, specifically, agitation, depression, and apathy, in nursing home residents suffering from dementia
Ethics approval(s)Ethics Committee of Charite - University Medicine Berlin approved on the 17th of July 2008 (ref: EA1/065/08)
Health condition(s) or problem(s) studiedNeuropsychiatric symptoms in dementia
Intervention18 care centres in Berlin will be randomised to the intervention or control conditions:
1. Intervention centres:
1.1. 20 hours of training for nursing staff on causes, symptomatology and treatment of neuropsychiatric symptoms in dementia
1.2. 4 hours of training for primary care psychiatrists on causes and medical treatment of neuropsychiatric symptoms in dementia
1.3. 15 minute individual occupational therapy sessions twice a week
1.4. Provision of and training in standardized assessments of neuropsychiatric symptoms in dementia (nursing staff)
2. Control centres: treatment as usual

The total duration of the intervention and follow up will be 9 months
Intervention typeOther
Primary outcome measure1. Agitation as measured with the Cohen-Mansfield Agitation inventory (CMAI)
2. Depression as measured with the Dementia Mood Assessment Scale (DMAS)
3. Apathy as measured with the Apathy Evaluation Scale (AES)
All primary outcomes are measured at baseline and at 12 months.
Secondary outcome measures1. Psychotropic medication in defined daily dosages
2. Number of hospital admissions
3. Caregiver burden as measured with the Perceived Stress Scale (PSS)
4. Mortality
All secondary outcomes are measured at baseline, months 3, 6, and 12, and mortality dates are ascertained retrospectively.
Overall study start date01/11/2008
Completion date01/05/2010

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants400 (from 18 Berlin nursing homes)
Key inclusion criteriaBoth male and female dementia patients aged 60 or older who live in a nursing home
Key exclusion criteria1. Inability to give informed consent and absence of a caregiver holding power of attorney
2. Any of the following conditions as defined by ICD-10 criteria
2.1. Presence of substance abuse (F 10)
2.2. Schizophrenia and associated conditions (F20)
2.3. Bipolar disorder (F30,31)
Date of first enrolment01/11/2008
Date of final enrolment01/05/2010

Locations

Countries of recruitment

  • Germany

Study participating centre

Psychiatric University Hospital St. Hedwig
Berlin
10115
Germany

Sponsor information

Federal Office of Administration (Bundesverwaltungsamt [BVA]) (Germany)
Government

Eupener Str. 125
Koeln
50728
Germany

Website http://www.bundesverwaltungsamt.de
ROR logo "ROR" https://ror.org/04n9aye53

Funders

Funder type

Government

German Federal Ministry of Health (Bundesministerium für Gesundheit [BMG]) (ref: LT 44-076)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2013 Yes No